Survival Outcomes in T3N0 versus N1 in Head and Neck Cutaneous Squamous Cell Carcinoma – Implications for Neoadjuvant Immune Checkpoint Inhibitor Immunotherapy - A.E. Yung; Y.J. Jeong; A.H. Varey; S.N. Lo; R. Gupta; R. Wu; M. Dunn; J.H. Lee; T.-H.H. Low; K.F. Shannon; J.R. Clark; S. Ch'ng (EJC Skin Cancer, 2024)